You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
2 May 2025 - Blue Earth Therapeutics, a UK-based developer of radiopharmaceutical therapies, on Thursday reported further progress in the development of its radio-hybrid, lutetium-labelled, PSMA targeted, investigational radioligand therapy for metas...
2 May 2025 - RNA oncology company TransCode Therapeutics Inc (NASDAQ:RNAZ) on Thursday reported further progress in its Phase 1a clinical trial of TTX-MC138 in patients with metastatic cancer.TTX-MC138 is a first-in-class therapeutic candidate design...
1 May 2025 - Ingenium Therapeutics, a South Korea-based clinical-stage biotechnology company advancing allogeneic natural killer (NK) cell therapies, announced on Wednesday that it has received positive regulatory feedback from the US Food and Drug A...
1 May 2025 -
At the 2025 Community Oncology Alliance Annual Meeting, group purchasing organisation AllyGPO and specialty distributor BioCareSD showcased their strategic partnership aimed at impro...
30 April 2025 - Nuformix plc (LSE: NFX), a pharmaceutical development company focused on unmet needs in fibrosis and oncology, confirmed on Wednesday that the European Medicines Agency's Committee for Orphan Medicinal Products (COMP) has issued ...
30 April 2025 - Investment company RTW Biotech Opportunities Ltd (LSE: RTW) on Wednesday announced the completion of a merger between its portfolio company Jade Biosciences and Aerovate Therapeutics. The combined entity will operate as Jade Bioscienc...
30 April 2025 - Clinical-stage biopharmaceutical company Atossa Therapeutics Inc (Nasdaq:ATOS) announced on Wednesday that it has been granted US Patent No. 12,281,056, expanding protection for its (Z)-endoxifen portfolio with 58 claims covering oral...